Literature DB >> 1794318

Hypoxanthine phosphoribosyl transferase deficiency, haematopoiesis and fertility in the mouse.

J D Ansell1, K Samuel, D G Whittingham, C E Patek, K Hardy, A H Handyside, K W Jones, A L Muggleton-Harris, A H Taylor, M L Hooper.   

Abstract

We have looked for effects of deficiency in hypoxanthine phosphoribosyl transferase (HPRT) in the mouse comparable to non-behavioural consequences of HPRT-deficiency in humans. HPRT-deficient humans show abnormalities in haematopoiesis and, in heterozygotes, there is strong selection in haematopoietic tissues against HPRT-deficient cells arising as a result of X-chromosome inactivation. We have examined two situations in mice in which HPRT- and HPRT+ cells occur in the same individual. First, in chimaeras resulting from the injection of HPRT- embryonal stem cells into HPRT+ blastocysts the fate of HPRT- and HPRT+ cell populations was monitored by their expression of different isozymes of glucose phosphate isomerase and also, in those chimaeras that resulted from injecting the male ES cells into female blastocysts, by in situ hybridisation using a Y-chromosome-specific repetitive DNA probe. There was a small statistically significant selection against the HPRT- population in haematopoietic tissues in both XX in equilibrium with XY and XY in equilibrium with XY chimaeras. Second, in female mice doubly heterozygous for HPRT-deficiency and for an electrophoretic variant of the X-linked enzyme phosphoglycerate kinase, there was a similar small statistically significant selection against the HPRT- population in haematopoietic tissues. While further work is required to establish whether this selection is a consequence of the HPRT mutation, it is clear that any selection against cells in the haematopoietic system as a consequence of HPRT-deficiency is at most small compared with the effect seen in humans. In HPRT-deficient human males surviving beyond the normal age of puberty, there is testicular atrophy. However, we find no effect of HPRT-deficiency on the fertility of either male or female mice. Thus, as with effects on behaviour, the consequences of HPRT-deficiency for haematopoiesis and testis development in the mouse are at most small compared with those in the human. We conclude that the reason for the difference in effects between the two species lies in a difference in purine-related intermediary metabolism per se, rather than in its interaction with brain amine biochemistry.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1794318     DOI: 10.1242/dev.112.2.489

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  10 in total

1.  Combined preconditioning and in vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrow.

Authors:  Katrin Hacke; Akos Szakmary; Andrew R Cuddihy; Nora Rozengurt; Nathan A Lemp; Jiri Aubrecht; Gregory W Lawson; Nagesh P Rao; Gay M Crooks; Robert H Schiestl; Noriyuki Kasahara
Journal:  Exp Hematol       Date:  2011-10-12       Impact factor: 3.084

Review 2.  Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells.

Authors:  M William Lensch; George Q Daley
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

3.  The unexpected landscape of in vivo somatic mutation in a human epithelial cell lineage.

Authors:  Lorel M Colgin; Alden F M Hackmann; Mary J Emond; Raymond J Monnat
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

4.  Bone marrow transplantation does not ameliorate the neurologic symptoms in mice deficient in hypoxanthine guanine phosphoribosyl transferase (HPRT).

Authors:  B E Wojcik; H A Jinnah; C E Muller-Sieburg; T Friedmann
Journal:  Metab Brain Dis       Date:  1999-03       Impact factor: 3.584

5.  Lesch-Nyhan syndrome and its pathogenesis: normal nicotinamide-adenine dinucleotide but reduced ATP concentrations that correlate with reduced poly(ADP-ribose) synthetase activity in HPRT-deficient lymphoblasts.

Authors:  G M McCreanor; R A Harkness
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.

Authors:  C E Patek; M H Little; S Fleming; C Miles; J P Charlieu; A R Clarke; K Miyagawa; S Christie; J Doig; D J Harrison; D J Porteous; A J Brookes; M L Hooper; N D Hastie
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 7.  Mouse models of hypoxanthine phosphoribosyltransferase deficiency.

Authors:  D J Williamson; M L Hooper; D W Melton
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

8.  PRTFDC1 is a genetic modifier of HPRT-deficiency in the mouse.

Authors:  Alaine C Keebaugh; Heather A Mitchell; Meriem Gaval-Cruz; Kimberly G Freeman; Gaylen L Edwards; David Weinshenker; James W Thomas
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

9.  CRISPR-Cas9 effectors facilitate generation of single-sex litters and sex-specific phenotypes.

Authors:  Charlotte Douglas; Valdone Maciulyte; Jasmin Zohren; Daniel M Snell; Shantha K Mahadevaiah; Obah A Ojarikre; Peter J I Ellis; James M A Turner
Journal:  Nat Commun       Date:  2021-12-03       Impact factor: 14.919

10.  Gonadal effects of a mouse Denys-Drash syndrome mutation.

Authors:  C E Patek; P T K Saunders; C G Miles; R L Berry; N D Hastie; R M Sharpe; M L Hooper
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.